Stocks Telegraph

BHC Stock Price History and Quote Analysis: Insights for Investors

NYSE:BHC

Bausch Health Companies Inc.

$6.20
-0.01-0.16%
At Close 4:00 PM
51.01
C+ESG ScoreESG Rating
Loading...

Stock Price Today

Bausch Health Companies Inc. (BHC) stock declined over -0.16%, trading at $6.20 on NYSE, down from the previous close of $6.21. The stock opened at $6.25, fluctuating between $6.17 and $6.45 in the recent session.

Stock Snapshot

6.21
Prev. Close
6.25
Open
2.28B
Market Cap
367.1M
Number of Shares
6.165
Day Low
6.445
Day High
-4.81
P/E Ratio
87.37%
Free Float in %
-1.29
EPS (TTM)
-2.8
Book Value
2.23
Cash Flow per Share
1.19M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Sep 09, 20246.256.456.176.201.18M
Sep 06, 20246.216.336.126.231.43M
Sep 05, 20246.276.316.126.20775.14K
Sep 04, 20246.036.316.016.231.09M
Sep 03, 20245.886.235.846.071.98M
Aug 30, 20245.915.985.865.931.27M
Aug 29, 20245.946.005.855.879.71M
Aug 28, 20245.935.975.835.90745.24K
Aug 27, 20245.966.045.925.971.06M
Aug 26, 20245.916.055.875.981.02M
Aug 23, 20245.815.945.765.87918.8K
Aug 22, 20245.855.885.725.77954.38K
Aug 21, 20245.895.915.725.83751.18K
Aug 20, 20245.735.875.735.83744.69K
Aug 19, 20245.755.805.725.75692.3K
Aug 16, 20245.725.815.665.73718K
Aug 15, 20245.655.885.625.74997.11K
Aug 14, 20245.505.555.465.53787.63K
Aug 13, 20245.425.495.355.47802.8K
Aug 12, 20245.425.565.415.411M

Contact Details

Laval, QC H7L 4A8

Canada

Website: https://www.bauschhealth.comContact: 151 474 46792

About Company

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Company Information

Employees20270
Beta0.753
Sales or Revenue$8.76B
5Y Sales Change%0.002%
Fiscal Year EndsDecember
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Frequently Asked Questions

What is the current Bausch Health Companies Inc. (BHC) stock price?

Bausch Health Companies Inc. (NYSE: BHC) stock price is $6.20 in the last trading session. During the trading session, BHC stock reached the peak price of $6.45 while $6.17 was the lowest point it dropped to. The percentage change in BHC stock occurred in the recent session was -0.16% while the dollar amount for the price change in BHC stock was -$0.01.

BHC's industry and sector of operation?

The NYSE listed BHC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Bausch Health Companies Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BHC?

Mr. John S. Barresi
Senior Vice President, Controller & Chief Accounting Officer
Mr. Donald Pearl
Senior Vice President of Ortho Dermatologics
Dr. Robert F. Butz
Vice President of Medical & Scientific Affairs
Mr. Arthur J. Shannon
Senior Vice President and Head of Investor Relations & Global Communications
Ms. Christina S. Cheng CFA
Senior Vice President of Investor Relations
Mr. Thomas J. Appio
Chief Executive Officer & Director
Mr. Thomas G. Vadaketh
Executive Vice President & Chief Financial Officer
Ms. Seana Carson
Executive Vice President & Gen. Counsel
Mr. Mirza Dautbegovic
Senior Vice President & Chief Operating Officer
Ms. Kathleen Fitzpatrick
Senior Vice President & Chief HR Officer
Dr. Tage Ramakrishna M.D.
Chief Medical Officer and Pres of R&D
Mr. Jeff Hartness
Executive Vice President of Market Access, Commercial Operations, Neurology, Generics & Gov. Affairs
Dr. Graham Jackson
Senior Vice President & Chief Quality Officer
Mr. Cees Heiman
Senior Vice President of Europe & Canada

How BHC did perform over past 52-week?

BHC's closing price is 56.57% higher than its 52-week low of $3.96 where as its distance from 52-week high of $11.46 is -45.9%.

How many employees does BHC have?

Number of BHC employees currently stands at 20,270.

Link for BHC official website?

Official Website of BHC is: https://www.bauschhealth.com

How do I contact BHC?

BHC could be contacted at phone 151 474 46792 and can also be accessed through its website. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, Canada.

How many shares of BHC are traded daily?

BHC stock volume for the day was 1.19M shares. The average number of BHC shares traded daily for last 3 months was 3.7M.

What is the market cap of BHC currently?

The market value of BHC currently stands at $2.28B with its latest stock price at $6.20 and 367.1M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now